Gene Techno Science
Financials
Estimates*
JPY | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
---|---|---|---|---|---|---|---|
Revenues | 1.1b | 997m | 1.6b | 2.8b | 2.4b | 470m | 560m |
% growth | - | (8 %) | 57 % | 77 % | (12 %) | (81 %) | 19 % |
EBITDA | (1.2b) | (974m) | (935m) | (589m) | (1.3b) | - | - |
% EBITDA margin | (110 %) | (98 %) | (60 %) | (21 %) | (56 %) | - | - |
Profit | (7.3b) | (1.0b) | (535m) | (657m) | (1.4b) | - | - |
% profit margin | (679 %) | (100 %) | (34 %) | (24 %) | (58 %) | - | - |
R&D budget | 898m | 964m | 1.2b | 1.2b | 1.5b | - | - |
R&D % of revenue | 83 % | 97 % | 73 % | 44 % | 60 % | - | - |
Date | Investors | Amount | Round |
---|---|---|---|
- | N/A | - | |
JPY500m | Late VC | ||
JPY508m | Late VC | ||
JPY488m | Late VC | ||
N/A | N/A | IPO | |
JPY1.2b | Early VC | ||
JPY2.9b Valuation: JPY2.9b | Acquisition | ||
Total Funding | CAD28.3m |
Related Content
Recent News about Gene Techno Science
EditG-GTS.com operates in the global trading solutions market, focusing on enhancing supply chain efficiency through advanced technology and data analytics. The company serves a diverse range of clients, including manufacturers, distributors, and retailers, who require streamlined logistics and supply chain management. G-GTS.com leverages a business model that integrates software-as-a-service (SaaS) with data-driven insights to optimize inventory management, reduce operational costs, and improve overall supply chain performance. Revenue is generated through subscription fees for its platform and additional services such as consulting and custom analytics.
Keywords: supply chain, logistics, data analytics, SaaS, inventory management, operational efficiency, global trading, technology, consulting, custom analytics.